APrevent Medical


APrevent is an innovative medical device company for voice and speech disorders.

Fundraising Status

Series A

Fundraising Target: 8M

Schedule: 

Q3 2023

Revenue (USD)

2022: 250K

2023 Target:  500K

Competitors

Boston Medical Products

Tobii

US Objective

Expected Results

Specific Organizations/VCs to Engage

Company Details

Short description

APrevent is dedicated to providing minimally invasive and innovative laryngeal implant and software-as-a-Service (SaaS) technologies for voice and speech disorders

Core Technology

VOIS and AiSpeak

APrevent One-Pager - Mark chang.pdf

Team Members

You can meet him in person:

5/1-4 SelectUSA Summit (Maryland)

5/5-8 TAcc+ Silicon Valley Spinoff

Media Exposures